MedPath

Comparison of Sevoflurane and Isoflurane Anesthesia for Benign Breast Tumor Excision

Phase 4
Completed
Conditions
Breast Neoplasms
Interventions
Registration Number
NCT00575354
Lead Sponsor
Nanjing Medical University
Brief Summary

Generally, benign breast tumors are excised under the local anesthesia. But such action was so invasive that every patient would experience the physiological and psychological stimuli unavoidably. Sevoflurane was advised as a better inhalational anesthesic for its "easy come,easy go" property during short-lasting operations than isoflurane. We purposed that sevoflurane would be a superior anesthesic for benign breast tumor excision than isoflurane with relative less alteration in hemodynamics, less postoperative side effects and easily-control the depth of anesthesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
500
Inclusion Criteria
  • Chinese
  • Diagnosed benign breast tumor patients
  • 18-64 yrs
Exclusion Criteria
  • Allergic to any interventional drugs
  • Organic dysfunction
  • Long-lasting PACU staying

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1SevofluraneSevoflurane: induction 3-6%, maintenance 2-3%
2IsofluraneIsoflurane: induction 3-6%, maintenance 2-3%
Primary Outcome Measures
NameTimeMethod
Time of induction, maintenance and resuscitation0h to the end of the operation
Secondary Outcome Measures
NameTimeMethod
Intraoperative hemodynamics; Postoperative side effects;0h to 24h after the end of the operation

Trial Locations

Locations (1)

Nanjing Maternal and Child Care Hospital

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath